Nkarta (NKTX) Net Cash Flow (2019 - 2026)
Nkarta's (NKTX) quarterly Net Cash Flow came in at -$12.3 million in Q1 2026, down 149.66% year-on-year from $24.7 million in Q1 2025, and up 40.05% quarter-over-quarter from -$20.5 million in Q4 2025.
Nkarta (NKTX) Net Cash Flow (2019 - 2026) Analysis & Trends
Nkarta's Net Cash Flow history runs 8 years deep, the most recent figure standing at -$12.3 million for Q1 2026.
- On a quarterly basis, Net Cash Flow fell 149.66% year-over-year to -$12.3 million in Q1 2026; TTM through Mar 2026 was -$25.2 million, a 87.23% increase from a year earlier, with the FY2025 full-year figure at $11.8 million, up 471.36% from the prior year.
- Net Cash Flow improved to -$12.3 million in Q1 2026 per NKTX's latest filing, from -$20.5 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $219.2 million in Q1 2024 and bottomed at -$129.9 million in Q2 2024.
- The 5-year median for Net Cash Flow is -$7.2 million (2023), against an average of -$1.9 million.
- Biggest YoY gain for Net Cash Flow was 1255.71% in 2024; the steepest drop was 793.69% in 2024.
- Year by year, Net Cash Flow stood at -$2.2 million in 2022, then slumped by 234.35% to -$7.2 million in 2023, then tumbled by 302.76% to -$29.1 million in 2024, then gained by 29.59% to -$20.5 million in 2025, then surged by 40.05% to -$12.3 million in 2026.
- Per Business Quant, the three latest NKTX Net Cash Flow figures stand at -$12.3 million (Q1 2026), -$20.5 million (Q4 2025), and $6.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Nkarta | 170.79 Mn | 170.79 Mn | - | -12.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.28 Mn |
| Mar 31, 2026 | -12.28 Mn |
| Dec 31, 2025 | -20.48 Mn |
| Dec 31, 2025 | -20.48 Mn |
| Sep 30, 2025 | 6.70 Mn |
| Sep 30, 2025 | 6.70 Mn |
| Jun 30, 2025 | 816,000.00 |
| Jun 30, 2025 | 816,000.00 |
| Mar 31, 2025 | 24.73 Mn |
| Mar 31, 2025 | 24.73 Mn |
| Dec 31, 2024 | -29.09 Mn |
| Dec 31, 2024 | -29.09 Mn |
| Sep 30, 2024 | -63.44 Mn |
| Sep 30, 2024 | -63.44 Mn |
| Jun 30, 2024 | -129.89 Mn |
| Jun 30, 2024 | -129.89 Mn |
| Mar 31, 2024 | 219.25 Mn |
| Mar 31, 2024 | 219.25 Mn |
| Dec 31, 2023 | -7.22 Mn |
| Dec 31, 2023 | -7.22 Mn |